SCHEMBL801509

SCHEMBL801509

c1ccc(-n2c3ccccc3c3cc(P(c4ccccc4)c4ccc5c(c4)c4ccccc4n5-c4ccccc4)ccc32)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.62
KDM4E B2RXH2 2/20 0.62
ATM Q13315 1/20 0.62
CYP3A4 P08684 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
ESR1 P03372 2/20 0.38
ESR2 Q92731 2/20 0.38
KMT2A Q03164 3/20 0.36
MAPK8 P45983 2/20 0.36
IL1R1 P14778 1/20 0.36
MAPK1 P28482 1/20 0.36
PGR P06401 1/20 0.36
ALDH1A1 P00352 3/20 0.36
MEN1 O00255 2/20 0.36
MAPT P10636 2/20 0.36
MAPK9 P45984 1/20 0.36
HTT P42858 1/20 0.36
KDR P35968 1/20 0.35
JAK2 O60674 1/20 0.35
JAK3 P52333 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL781505 1.00 L3MBTL1 (0.62) L3MBTL1KDM4EATMCYP3A4TDP1
SCHEMBL801793 0.97 KDM4E (0.57) L3MBTL1KDM4EATMCYP3A4TDP1
SCHEMBL782778 0.95 KDM4E (0.52) L3MBTL1KDM4EATMCYP3A4TDP1
SCHEMBL14910575 0.93 KDM4E (0.53) L3MBTL1KDM4EATMCYP3A4TDP1
SCHEMBL14910075 0.93 KDM4E (0.53) L3MBTL1KDM4EATMCYP3A4TDP1
SCHEMBL30775140 0.93 KDM4E (0.53) L3MBTL1KDM4EATMCYP3A4TDP1
SCHEMBL19362147 0.93 KDM4E (0.53) L3MBTL1KDM4EATMCYP3A4TDP1
SCHEMBL14909983 0.93 KDM4E (0.53) L3MBTL1KDM4EATMCYP3A4TDP1
SCHEMBL14948506 0.93 KDM4E (0.52) L3MBTL1KDM4EATMCYP3A4TDP1
SCHEMBL801203 0.91 KDM4E (0.47) L3MBTL1KDM4EATMCYP3A4TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278986-B2 Carbazole-based phosphine oxide compound, and organic electroluminescent device including the same SK CHEMICALS CO., LTD. (KR) 2016-03-08 US disclosed
US-9278986-B2 Carbazole-based phosphine oxide compound, and organic electroluminescent device including the same SK CHEMICALS CO., LTD. (KR) 2016-03-08 US disclosed
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) 2012-03-22 US disclosed
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INPP5B, EZH2, PLCB3 L3MBTL1 1822/4885KDM4E 1186/4885ATM 3758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.